Physician profile
Alexandre Fleury
NPI 1013040070
$271,288.42
in general payments reported to CMS, 2019-2025
4 companies · $94K in 2025
The $94K reported for 2025 was more than what 99% of Endodontics providers received nationally (typical 2025 total: $58.83).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $41K · 2022: $113 · 2023: $77K · 2024: $59K · 2025: $94K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $128K · Consulting Fee: $44K · Travel and Lodging: $41K · Royalty Or License: $17K · Food and Beverage: $217.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $127,526.53 |
| Consulting Fee | $44,000.00 |
| Travel and Lodging | $41,410.64 |
| Royalty Or License | $16,585.25 |
| Food and Beverage | $217.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Peter Brasseler Holdings, LLC | $271,073.68 | 2019-2025 | |
| Henry Schein, INC. | $93.67 | 2025 | |
| Abbott Laboratories | $70.66 | 2019 | |
| Septodont INC. | $50.41 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexandre Fleury listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.